AstraZeneca: Tagrisso + Orpathys Improved PFS In 1L EGFRM Lung Cancer
AstraZeneca: Tagrisso + Orpathys Improved PFS In 1L EGFRM Lung Cancer
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
AstraZeneca PLC notes improved PFS with Tagrisso + Orpathys in 1L EGFRm lung
AstraZeneca PLC said Tagrisso plus Orpathys improved PFS in first-line EGFRm lung cancer.